Healthline
March 19, 2025
Share on PinterestPeople who rely on compounded GLP-1 drugs say they might not be able to afford brand-name versions, which are often not covered by insurance. […]
March 18, 2025
Share on PinterestHeavy menstrual bleeding is common during perimenopause and can lead to iron deficiency anemia, a well-known cause of fatigue. Maskot/Getty Images A recent study […]
March 17, 2025
Share on PinterestThe CDC reports that 95% of measles cases in the U.S. are in people who are unvaccinated or whose vaccination status is unknown. FG […]
March 16, 2025
Share on PinterestIn Season 3 of “The White Lotus,” some characters pop lorazepam like candy, highlighting the potential for dependency and misuse. CHANAKARN LAOSARAKHAM/AFP via Getty […]
Medscape
May 9, 2025
Ever since The Pitt debuted on MAX earlier this year, emergency room (ER) personnel across the country, from registered nurses to residents to doctors, are talking […]
May 9, 2025
The annual switch to daylight saving time (DST) in many parts of the world is detrimental to public health and should be abolished in favor of […]
May 8, 2025
The US Food and Drug Administration (FDA) has granted accelerated approval of combination avutometinib and defactinib (Avmapki Fakzynja Co-pack, Verastem, Inc.) for the treatment of certain […]
May 8, 2025
AMSTERDAM — Today, the EU launched a new coalition of health organizations and experts to advocate for the reduction of alcohol-related illnesses, injuries, and deaths here […]
FDA
March 31, 2025
Alecensa (alectinib) capsules Alunbrig (brigatinib) tablets Lorbrena (lorlatinib) tablets Zykadia (ceritinib) capsules; tablets Optic neuropathy FDA is evaluating the need for regulatory action. Antidepressants Selective serotonin […]
March 31, 2025
Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Mr. Mingzhong Su Recipient Title President Sani-Care Salon Products, Inc. 51 Curtis Court, Ste. BCartersville, GA […]
March 28, 2025
On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent durvalumab as […]
March 28, 2025
For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of […]
